NCT02785770 - A Study To Evaluate The Effect Of PF-04447943 On Qtc Interval In Healthy Adult Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 29, 2016

Primary Completion Date

October 20, 2016

Study Completion Date

October 20, 2016

Conditions

Healthy

Interventions

DRUG

PF-04447943

Single oral dose of PF-04447943 administered as an extemporaneously prepared solution

DRUG

Placebo

Single oral dose of matching placebo for PF-04447943 administered as an extemporaneously prepared solution

DRUG

Moxifloxacin

Single oral dose of moxifloxacin administered as tablet

Trial Locations (1)

Pfizer New Haven Clinical Research Unit, New Haven